Abstract
Fahr’s disease is a rare neurodegenerative syndrome, characterized by massive symmetrical intracerebral calcifications of the basal ganglia, dentate nuclei of the cerebellum, and the adjacent parenchyma. Computerized tomography (CT) is considerably more sensitive to detect these intracranial calcifications than other imaging modalities. The clinical, CT scan, and 99mTc-D,L-hexamethylpropylene amine oxime (99mTc-HMPAO) brain perfusion single-photon emission computerized tomography (SPECT) findings in a 42-year-old woman with Fahr’s disease are reported, and the clinical utility of 99mTc-HMPAO SPECT findings in Fahr’s disease is discussed in this article. In conclusion, 99mTc-HMPAO brain perfusion SPECT seems to be useful in the clinical approach to Fahr’s disease, and may provide more specific and clinically relevant information when compared with anatomical imaging.
Similar content being viewed by others
References
Bamberger PH. Beobactungen und bemerkungen uber hirnkrankheiten. Verh Phys Med Ges Wurzburg 1855;6:325–328.
Fahr TH. Idiopathische verkalkung der hirngefasse. Zentralbl Allg Pathol 1930;50:129–133.
Flint J, Goldstein LH. Familial calcification of the basal ganglia: a case report and review of the literature. Psychol Med 1992;22:581–595.
Rasmussen MJ, Pilo L, Nielsen HR. Basal ganglia calcifications demonstrated by CT. Is further investigation necessary when this is found incidentally? Ugeskr Laeger 1991;153:2051–2053.
Manyam BW, Bhatt MH, Moore WD, Devleschoward AB, Anderson DR, Calne DB. Bilateral striopallidodentate calcinosis: cerebrospinal fluid, imaging, and electrophysiological studies. Ann Neurol 1992;31:379–384.
Ellie E, Julien J, Ferrer X. Familial idiopathic striopallidodentate calcifications. Neurology 1989;39:381–385.
Smits MG, Gabreels FJ, Thijssen HO, ’tLam RL, Notermans SL, ter Haar BG, et al. Progressive idiopathic strio-pallidodentate calcinosis (Fahr’s disease) with autosomal recessive inheritance. Eur Neurol 1983;22:58–64.
Smith FW, Gemmell HG, Sharp PF, Besson JA. Technetium-99m HMPAO imaging in patients with basal ganglia disease. Br J Radiol 1988;61:914.
Uygur GA, Liu Y, Hellman RS, Tikofsky RS, Collier BD. Evaluation of regional cerebral blood flow in massive intracerebral calcifications. J Nucl Med 1995;36:610.
De Cristofaro MT, Sessarego A, Pupi A, Biondi F, Faravelli C. Brain perfusion abnormalities in drug naive, lactate-sensitive panic patients: a SPECT study. Biol Psychiatry 1993;33:505–512.
Murphy MJ. Clinical correlations of CT scan-detected calcifications of the basal ganglia. Ann Neurol 1979;6:507–511.
Vles JS, Lodder J, van der Lugt PJ. Clinical significance of basal ganglia calcifications detected by CT (a retrospective study of 33 cases). Clin Neurol Neurosurg 1981;83:253–256.
Harrington MG, Macpherson P, McIntosh WB, Allam BF, Bone I. The significance of the incidental finding of basal ganglia calcification on computed tomography. J Neurol Neurosurg Psychiatry 1981;44:1168–1170.
Stellamor K, Stellamor V. Roentgen diagnosis of Fahr’s disease. Roentgenblatter 1983;36:194–196.
Kazis AD. Contribution of CT scan to the diagnosis of Fahr’s syndrome. Acta Neurol Scand 1985;36:194–196.
Konig P. Psychopathological alterations in cases of symmetrical basal ganglia sclerosis. Biol Psychiatry 1989;25:459–468.
Kendall B, Cavanagh N. Intracranial calcification in pediatric computed tomography. Neuroradiology 1986;28:324–330.
Taxer F, Haller R, König P. Klinische frühsymptome und CT-Befunde beim Fahr’schen syndrom. Nervenarzt 1986;57:583–588.
Norman D, Diamond C, Boyd D. Relative detectability of intracranial calcifications on computed tomography and skull radiography. J Comput Assist Tomogr 1978;2:61.
Holland BA, Kucharcyzk W, Brant-Zawadzki M, Norman D, Haas DK, Harper PS, et al. MR imaging of calcified intracranial lesions. Radiology 1985;157:353.
Oot RF, New PFJ, Pile-Spellman J, Rosen BR, Shoukimas GM, Davis KR. The detection of intracranial calcifications by MR. AJNR Am Neurolradiol 1986;7:801.
Henkelman RM, Watts JF, Kucharczyk W. High signal intensity in MR images of calcified brain tissue. Radiology 1991;179:199.
Scotti G, Scialfa G, Tampieri D, Landoni L. MR imaging in Fahr disease. J Comput Assist Tomogr 1985;9:790.
Alexander GE, De Long MR, Strick PL. Parallel organization of functionally segregated circuits linking basal basal ganglia and cortex. Annual Review of Neuroscience 1986;9:357–381.
Ogi S, Fukumitsu N, Tsuchida D, Uchiyama M, Mori Y, Matsui K. Imaging of bilateral striopallidodentate calsinosis. Clin Nucl Med 2002;27:721–724.
Shouyama M, Kitabata Y, Kaku T, Shinosaki K. Evaluation of regional cerebral blood flow in Fahr disease with schizophrenia-like psychosis: A case report. AJNR Am J Neuroradiol 2005;26:2527–2529.
Hempel A, Henze M, Berghoff C, Garcia N, Ody R, Schroder J. PET findings and neuropsychological deficits in a case of Fahr’s disease. Psychiatry Res 2001;108:133–140.
Benke T, Karner T, Seppi K, Delazer M, Marksteiner J, Donnemiller E. Subacute dementia and imaging correlates in a case of Fahr’s disease. J Nuerol Neurosurg Psychiatry 2007;75:1163–1165.
Le Ber I, Marie RM, Lalevee C, Chabot B, Allouche S, Defer GL. Familial idiopathic striato-pallido-dentate calcifications: clinical and brain imaging study in a family. Rev Neurol (Paris) 2003;159:43–49.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ones, T., Dede, F., Gunal, D. et al. The clinical utility of 99mTc-HMPAO SPECT in Fahr’s disease. Ann Nucl Med 22, 425–428 (2008). https://doi.org/10.1007/s12149-007-0121-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12149-007-0121-0